Ionis Pharmaceuticals (IONS) Tops Q4 EPS by 55c

Ionis Pharmaceuticals (NASDAQ: IONS) reported Q4 EPS of ($0.37), $0.55 better than the analyst estimate of ($0.92). Revenue for the quarter came in at $152 million versus the consensus estimate of $158.8 million.

For earnings history and earnings-related data on Ionis Pharmaceuticals (IONS) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Horizon Bancorp faces $3M jury verdict in auto repossession case
• Alcoa agrees to buy South32 assets for $4.1 billion